Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-01-29
2008-01-29
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S300100, C548S335100, C514S385000
Reexamination Certificate
active
07323485
ABSTRACT:
Compounds of Formula 1where X is S and the variables have the meaning defined in the specification are specific or selective to alpha2Band/or alpha2Cadrenergic receptors in preference over alpha2Aadrenergic receptors, and as such have no or only minimal cardivascular and/or sedatory activity. These compounds of Formula 1 are useful as medicaments in mammals, including humans, for treatment of diseases and or alleviations of conditions which are responsive to treatment by agonists of alpha2Badrenergic receptors. Compounds of Formula 1 where X is O also have the advantageous property that they have no or only minimal cardivascular and/or sedatory activity and are useful for treating pain and other conditions with no or only minimal cardivascular and/or sedatory activity.
REFERENCES:
patent: 3996366 (1976-12-01), Baker et al.
patent: 4798834 (1989-01-01), Merritt et al.
patent: 5441970 (1995-08-01), Reitz et al.
patent: 5648373 (1997-07-01), Winkler et al.
patent: 5861420 (1999-01-01), Reitz et al.
patent: 5929103 (1999-07-01), Yoon et al.
patent: 5932742 (1999-08-01), Yoon et al.
patent: 6043373 (2000-03-01), Yoo et al.
patent: 6313172 (2001-11-01), Chow et al.
patent: 6534542 (2003-03-01), Chow et al.
patent: 6545182 (2003-04-01), Chow et al.
patent: 7091232 (2006-08-01), Chow et al.
patent: 7141597 (2006-11-01), Chow et al.
patent: 7183305 (2007-02-01), Dolby et al.
patent: 2002/0094998 (2002-07-01), Burke et al.
patent: 1 499 485 (1978-02-01), None
patent: WO 92/00073 (1992-01-01), None
patent: WO 99/28300 (1999-06-01), None
patent: WO 01/00586 (2001-01-01), None
patent: WO 02/36162 (2002-05-01), None
patent: WO 03/099795 (2003-12-01), None
Berque et al.,Allyltitanates in Stereospecific Additions to Chiral o-Lactol: Efficient Enantioselective Route to a Potential Precursor of the C1-C9 Portion of Tylonlide, J. Org. Chem., 1999, 373-381.
Ciufolini et al.,The Total Synthesis of Cystodytins, J. Amer. Chem. Soc., 1991, 113, 8016-8024.
Conklin et al.,Substitution of three amino acids switches receptor specificity of Gqa to that of G1aNature, 1993, p. 274-276, 363.
Cooke et al.,Silicon in Synthesis, 8.1Vinyltrimethylsilane, a convenient ethylene equivalent for the Synthesis of Vinyl Arl Sulfides, Vinyl Aryl Sulfoxides, Thiosilketene Acetals, and Fused Cyclopentenones, J. Org. Chem., 1980, 45, 1046-1053.
Corey et al.,A new chiral catalyst for the enantioselective synthesis of secondary alcohols and deuterated primary alcohols by carbonyl reduction, Tetrahedron Letters, 1989, 30, 6275-6278.
Dirig, et al.,Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermalstimuli, J. Neurosci. Methods, 1997, 76, p. 183-191.
Dixon et al.,Efficient Analysis of Experimental Observations, Ann. Rev. Pharmacol. Toxicol., 1980, 20, p. 441-462.
Hargreaves, et al.,A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia, Pain, 1988, 32, p. 77-88.
Horne et al.,A two-step synthesis of imidazoles from aldehydes via 4-tosyloxazolines, Heterocycles, 1994, 39, 139.
Hua et al.,A one-pot condensation of pyrones and enals. Synthesis of 1H,7H-5a,6,8,9-Tetrahydro-1-oxopyrano[4,3-b][1]benzopyrans J. Org. Chem. 1997, 62, 6888-6896.
Huang et al.,The Improved Preparation of 7,8-dihydro-quinoline-5(gH)-One and 6,7-dihydro-6H-1-pyrindin-5-one, Synthetic Communications, 1998, 28, 1197-1200.
Jackman, et al. (1949): STN International CAPLUS data base, Columbus, Ohio, Accession No. 1949:2664.
Jenneskens, et al.,Flash vacuum thermolysis of 5,6,8,9-tetrahydro-4'-methylenespiro[7H-benzocycloheptene-7,1'-cyclohexa-2'5'-diene]. The intermediate formation of [3,2]orthoparacyclophane, J. Org. Chem. 1986, 51, 2162-2168.
Kim et al.,an experimental model for peripheral neuropathy produced by segmental spinal nerve litigation in therat, Pain, 1992, 50, p. 355-363.
Kim et al.,A facile synthesis of a-chloro enones by oxidativechlorination, Synthesis, 1993, 283.
Kowalski et al.,a-Keto dianion precursors via conjugate additions to cyclic a-bromoenones, J. Org. Chem., 1982, 47, 5088-5093.
Lemke et al.,Synthesis of 5,6-dihydro-8(7H)-quinolinone thiosemicarbazones as potential antitumoragents, J. Med. Chem., 1977, 20, 10, 1351.
Mancuso,Activated dimethyl sulfoxide: useful reagents forsynthesis, Synthesis, 1981, p. 165.
Messier et al.,High throughput Assays of cloned adrenegeric, muscarinic, neurokinin, and neurotrophin receptors in living mammaliancells, Pharmacol. Toxicol., 1995, 76, 308-311.
Molina et al.,Vinyliminophosphorane-mediated preparation of 2-arylquinoline and 4-aryl-1-azaanthraquinone derivatives, x-ray crystal structure of 1,2-dihydro-3H-indazolo[2,3-a]quinolin-4-one, Tetrahedron, 1995, 51, 1265-1276.
Organ et al.,Ni-catalyzed cross coupling of alkoxide-containing vinyl halides with grignard reagents. A “one-pot” synthesis of 2-[trimethylsilyl]-2-propen-1-yl acetate, J. Org. Chem., 1997, 62, 1523-1526.
Sosa et al.,Synthesis ofaxinohydantoins, J. Org. Chem., 2002, 67, 4498-4500.
Woods et al.,Synthesis with Dihydrorescorcinol mono ethyl ether: 3-alkykl-a2-cyclohexenones, J. Amer. Chem. Soc., 1949, 71, 2028-2031.
Xavier et al., (s)-tetrahydro-1-methyl-3,3-diphenyl-1H,3H-pyrrolo-[1,2-c][1,3,2]oxazaborole-n7)-, [1-4-(3aS-cls)]-), Organic Synthesis, 1996, 50, 74.
Yoon, et al. (1998):STN International CAPLUS data base, Columbus, Ohio, Accession No. 1998: 147327.
Chow Ken
Garst Michael E.
Gil Daniel W.
Heidelbaugh Todd M.
Wheeler Larry A.
Allergan Inc.
Johnson Brent A.
Shameem Golam M. M.
Voet Martin A.
LandOfFree
4-(substituted cycloalkylmethyl) imidazole-2-thiones,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-(substituted cycloalkylmethyl) imidazole-2-thiones,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(substituted cycloalkylmethyl) imidazole-2-thiones,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2795915